α-synuclein as an emerging pathophysiological biomarker of Alzheimer’s disease-Reference-Cited by-同舟云学术

α-synuclein as an emerging pathophysiological biomarker of Alzheimer’s disease

Published:2022-04-03 Issue:4 Volume:22 Page:411-425
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Beatino Maria Francesca¹,De Luca Ciro²,Campese Nicole¹,Belli Elisabetta¹,Piccarducci Rebecca³,Giampietri Linda¹,Martini Claudia³,Perugi Giulio¹,Siciliano Gabriele¹,Ceravolo Roberto¹,Vergallo Andrea⁴,Hampel Harald⁴,Baldacci Filippo¹⁴^ORCID

Affiliation:

1. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

2. Laboratory of Neuronal Network Morphology and Systems Biology, Department of Mental and Physical Health and Preventive Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy

3. Department of Pharmacy, University of Pisa, Pisa, Italy

4. GRC N° 21, Alzheimer Precision Medicine (APM), Sorbonne University, AP-HP, Pitié-Salpêtrière Hospital, Boulevard De l’Hôpital, Paris, France

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2022.2068952

Reference127 articles.

1. Alzheimer's disease

2. Developing the ATX(N) classification for use across the Alzheimer disease continuum

3. Hampel H, Hardy J, Blennow K, et al. The Amyloid-β Pathway in Alzheimer’s Disease. Mol Psychiatry [Internet]. 2021 [cited 2021 Dec 11]; Available from: https://pubmed.ncbi.nlm.nih.gov/34456336/

4. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

5. Comorbidities

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical Repurposing Strategies for Metabolic Disorders: Insights from Mendelian Randomization Studies;2024-03-30

2. Protein Aggregation in Neurodegeneration;Encyclopedia of Life Sciences;2024-03-27

3. Application of blood-based biomarkers of Alzheimer's disease in clinical practice: Recommendations from Taiwan Dementia Society;Journal of the Formosan Medical Association;2024-01

4. Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A2A Adenosine Receptor Useful in Neurodegenerative Disorders;Molecules;2023-06-14

5. Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease;Frontiers in Neurology;2023-05-24